BioSpace News Archive

NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it will be featured as a presenting company at the H.C. Wainwright BioConnect Virtual Conference to be held January 10-13, 2022.

Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 8:15 a.m. EST.

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced its strategic priorities for 2022 and highlighted recent achievements from its broad immunology pipeline.

Pharyngitis is the medical condition that causes inflammation at the back of the throat which is known as pharynx.

The demand for ocular inserts increased considerably in the past few years due to increasing incidences of glaucoma and other eye diseases.

A dental hand piece is a tool which is used to drill into specific areas of the tooth with high and low speed.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, by 2031, the global market for self-care medical devices is expected to be worth $3 billion.

Vesicoureteral reflux treatment is the medical condition characterized by the abnormal flow of urine form the bladder to the upper urinary tract.

Neurimmune AG announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s Rare Disease group, to develop NI006, an investigational human monoclonal antibody specifically targeting misfolded transthyretin.

CareDx, Inc. today announced the results of a study led by the National Institutes of Health.